Literature DB >> 9738722

Primary human herpesvirus 7 infection: a comparison of human herpesvirus 7 and human herpesvirus 6 infections in children.

M T Caserta1, C B Hall, K Schnabel, C E Long, N D'Heron.   

Abstract

OBJECTIVE: To define the clinical and virologic characteristics of primary human herpesvirus 7 (HHV-7) infection and to compare these characteristics with those of primary human herpesvirus 6 (HHV-6) infection. STUDY
DESIGN: A prospective convenience sample study of 496 children < or =3 years old. HHV-7 and HHV-6 infections were identified by viral isolation. Polymerase chain reaction and serology for HHV-7 and HHV-6 were performed. Clinical and laboratory characteristics of patients were obtained from medical records and follow-up interviews.
RESULTS: Children with primary HHV-7 infection (n = 8) were identified and compared with children with primary HHV-6 infection (n = 29) detected during the same time period. All children were febrile (mean temperature 39.8 degrees C) with no difference in the degree of fever, frequency of rash, or gastrointestinal complications between the groups. The median age of children with primary HHV-7 infection was 26 months, significantly older than that of children with primary HHV-6 infection (median, 9 months). Children with primary HHV-7 infection were also more likely than those with primary HHV-6 infection to have seizures associated with the illness (P = .004).
CONCLUSION: Primary infection with HHV-7 can cause a highly febrile illness in childhood, complicated by seizures. The serologic diagnosis of primary HHV-6 and HHV-7 infections may be confounded by cross-reacting antibodies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9738722     DOI: 10.1016/s0022-3476(98)70275-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  Febrile Seizures and Mesial Temporal Sclerosis.

Authors:  Shlomo Shinnar
Journal:  Epilepsy Curr       Date:  2003-07       Impact factor: 7.500

2.  Use of immunoglobulin G antibody avidity for differentiation of primary human herpesvirus 6 and 7 infections.

Authors:  K N Ward; D J Turner; X C Parada; A D Thiruchelvam
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  Evaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler's murine encephalomyelitis virus mouse model.

Authors:  Melissa L Barker-Haliski; E Jill Dahle; Taylor D Heck; Timothy H Pruess; Fabiola Vanegas; Karen S Wilcox; H Steve White
Journal:  J Pharmacol Exp Ther       Date:  2015-03-09       Impact factor: 4.030

4.  Invasion by human herpesvirus 6 and human herpesvirus 7 of the central nervous system in patients with neurological signs and symptoms.

Authors:  T Yoshikawa; M Ihira; K Suzuki; S Suga; T Matsubara; S Furukawa; Y Asano
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

5.  Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland.

Authors:  K N Ward; N J Andrews; C M Verity; E Miller; E M Ross
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

Review 6.  Clinical impact of primary infection with roseoloviruses.

Authors:  Brenda L Tesini; Leon G Epstein; Mary T Caserta
Journal:  Curr Opin Virol       Date:  2014-10-14       Impact factor: 7.090

7.  Association of human herpesvirus 6 and human herpesvirus 7 with demyelinating diseases of the nervous system.

Authors:  V Tomsone; I Logina; A Millers; S Chapenko; S Kozireva; M Murovska
Journal:  J Neurovirol       Date:  2001-12       Impact factor: 2.643

Review 8.  Human herpes virus 6B: a possible role in epilepsy?

Authors:  William H Theodore; Leon Epstein; William D Gaillard; Shlomo Shinnar; Mark S Wainwright; Steven Jacobson
Journal:  Epilepsia       Date:  2008-07-08       Impact factor: 5.864

9.  Human herpesvirus 6 and 7 in febrile status epilepticus: the FEBSTAT study.

Authors:  Leon G Epstein; Shlomo Shinnar; Dale C Hesdorffer; Douglas R Nordli; Aaliyah Hamidullah; Emma K T Benn; John M Pellock; L Matthew Frank; Darrell V Lewis; Solomon L Moshe; Ruth C Shinnar; Shumei Sun
Journal:  Epilepsia       Date:  2012-06-14       Impact factor: 5.864

10.  A Celebration of the Life and Work of Caroline Breese Hall, MD.

Authors:  Geoffrey A Weinberg
Journal:  J Pediatric Infect Dis Soc       Date:  2014-12-08       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.